Gastrointestinal Stromal Tumor (GIST) Therapeutics Market value of US$ 1593 Million by registering a CAGR of 6% in the forecast period 2023 to 2033

During the forecast period 2023 to 2033, the Gastrointestinal stromal tumor (GIST) therapeutics market is expected to grow at a value of 6% CAGR, according to Future Market Insights. By the year 2033, the global market for Gastrointestinal stromal tumor (GIST) therapeutics is expected to rise up to a market valuation of US$ 1593 Million. An aging …

Europe Salivary gland infection treatment market size is expected to possess 43% market share in 2023

During the forecast period 2023 to 2033, the Salivary gland infection treatment market is expected to grow at a value of 9.3% CAGR, according to Future Market Insights. By the year 2033, the global market for Salivary gland infection treatment is expected to rise up to a market valuation of US$ 12,300 Million. The growth of the …

Stone Analysis Software Market is expected to reach a net worth of US$ 72.9 Million by 2032 | FMI Study

The stone analysis software market is poised to witness a CAGR of 3.2% during the forecast period. Over this projection period, the stone analysis software market share is estimated to reach a net worth of US$ 72.9 Million by 2032, improving from the current valuation of US$ 51.7 Million in 2022. Kidney stone analysis test is widely adopted throughout the world …

Catheter-Directed Thrombolysis Market is predicted to advance at a CAGR of 5.9% from 2022 to 2032 | FMI Study

[324 Pages Report] The global catheter-directed thrombolysis market is expected to be worth US$ 432.0 million in 2022, rising at a 5.9% CAGR to be worth US$ 814.0 million by 2032. Catheter-directed Thrombolysis Infection Market: Drivers and Restraints The primary factor driving the growth of catheter-directed thrombolysis market is increasing the prevalence of stroke, pulmonary embolism and deep vein …

Substance Use Disorder Treatment Market is forecasted to be expected at US$ 14 Million by 2032 | FMI Study

[323 Pages Report] The global substance use disorder treatment market is forecasted to be estimated at US$ 14 Mn by 2032, up from US$ 7 Mn in 2022, advancing at a CAGR of 5.4% during the forecast period. Substance Use Disorder Treatment Market: Overview The global market for substance use disorder treatment is expected to witness moderate growth over the forecast …

Hand Eczema (HE) Treatment Market value of US$ 114.42 Million by registering a CAGR of 8% from 2023 to 2033 | FMI

The global Hand Eczema (HE) Treatment Market is expected to garner a market value of US$ 53 Million in 2023 and is expected to accumulate a market value of US$ 114.42 Million by registering a CAGR of 8% in the forecast period 2023 to 2033. The market for Hand Eczema (HE) Treatment registered a CAGR of 4% in the historical period 2018 to 2022. According …

Cancer Biopsy Market is projected to increase at a CAGR of around 18% from 2023 to 2033

The Cancer Biopsy market revenues were estimated at US$ 22.2 Bn in 2022 and is anticipated to grow at a CAGR of 18% from 2023-2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 131.4 Bn. The increasing elderly populace, along with the rise in instances of cancer …

Spine Pain Market is projected to exhibit a compound annual growth rate (CAGR) of 5% from 2023 to 2033

The market for treating spinal pain is anticipated to reach US$ 7.65 billion in 2023 and grow at a 5% compound annual growth rate (CAGR) from 2023 to 2033. The market is predicted to reach US$ 12.47 billion by the end of the assessment period in question. According to Future Market Insights’ recent report, the spine pain market is …

Patient-Controlled Analgesia Pumps Market to reach US$ 699.9 Million by the year 2032 | FMI

The market for patient-controlled analgesia pumps is anticipated to reach US$ 421.9 million in 2022 and grow at a CAGR of 5.2% to US$ 699.9 million by 2032. PCA pumps will dominate the market globally in 2021, according to a recent study by Future Market Insights, with a share of roughly 75.5%. PCA or patient-controlled analgesia pumps …

Self-testing Market is projected to rise to US$ 13.6 billion by 2033 | FMI

In 2023, the self-testing market is expected to reach a valuation of US$7.89 billion, according to the FMI. By 2033, it is anticipated that the market will grow to $13.6 billion USD. For the forecast period, the market is securing a CAGR of 5.6%. Consumers are swiftly adapting to buy self-testing kits due to early detection of …